ACOG Committee Opinion No. 451: Von Willebrand disease in women.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 20134302.
- Also identified by DOI 10.1097/AOG.0b013e3181c6f975.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Approximately 3 million women in the United States have inherited bleeding disorders. The prevalence of bleeding disorders is particularly high among women with menorrhagia. Von Willebrand disease is the most common inherited bleeding disorder. Once a diagnosis is made, collaboration with a hematologist is helpful for long-term management. Women with von Willebrand disease may be at increased risk for gynecologic and obstetric complications. Many treatments are available for the control of menorrhagia in women with von Willebrand disease, but the first-line therapy remains combined hormonal contraception.
Medical subject headings
- Contraceptives, Oral, Combined
- Menorrhagia
- von Willebrand Diseases